Skip to Main Content

Paper Details

Should modulation of p50 be a therapeutic target in the critically ill?
Expert Rev Hematol
21
2017
Author NameAffiliation
Amudan J Srinivasana Duke University School of Medicine
Ian J WelsbyDuke University Medical Center
  • 1 - 2

Datasets

Release 1.2